These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9740097)

  • 1. Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride binding.
    Ito H; Hietala J; Blomqvist G; Halldin C; Farde L
    J Cereb Blood Flow Metab; 1998 Sep; 18(9):941-50. PubMed ID: 9740097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion.
    Carson RE; Breier A; de Bartolomeis A; Saunders RC; Su TP; Schmall B; Der MG; Pickar D; Eckelman WC
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):437-47. PubMed ID: 9143226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain.
    Olsson H; Halldin C; Swahn CG; Farde L
    J Cereb Blood Flow Metab; 1999 Oct; 19(10):1164-73. PubMed ID: 10532641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution volume ratios without blood sampling from graphical analysis of PET data.
    Logan J; Fowler JS; Volkow ND; Wang GJ; Ding YS; Alexoff DL
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):834-40. PubMed ID: 8784228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats.
    Ginovart N; Wilson AA; Houle S; Kapur S
    Biol Psychiatry; 2004 Jun; 55(12):1188-94. PubMed ID: 15184038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic modeling of [11C]raclopride: combined PET-microdialysis studies.
    Endres CJ; Kolachana BS; Saunders RC; Su T; Weinberger D; Breier A; Eckelman WC; Carson RE
    J Cereb Blood Flow Metab; 1997 Sep; 17(9):932-42. PubMed ID: 9307606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
    Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiinjection approach for D2 receptor binding quantification in living rats using [11C]raclopride and the beta-microprobe: crossvalidation with in vitro binding data.
    Mauger G; Saba W; Hantraye P; Dolle F; Coulon C; Bramoullé Y; Chalon S; Grégoire MC
    J Cereb Blood Flow Metab; 2005 Nov; 25(11):1517-27. PubMed ID: 15917750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of dynamic neurotransmitter changes with bolus or infusion delivery of neuroreceptor ligands.
    Endres CJ; Carson RE
    J Cereb Blood Flow Metab; 1998 Nov; 18(11):1196-210. PubMed ID: 9809509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysis.
    Hietala J; Någren K; Lehikoinen P; Ruotsalainen U; Syvälahti E
    J Cereb Blood Flow Metab; 1999 Feb; 19(2):210-7. PubMed ID: 10027776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis.
    Farde L; Eriksson L; Blomquist G; Halldin C
    J Cereb Blood Flow Metab; 1989 Oct; 9(5):696-708. PubMed ID: 2528555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig: a dual tracer PET study with [11C]harmine and [11C]raclopride.
    Jensen SB; Olsen AK; Pedersen K; Cumming P
    Synapse; 2006 Jun; 59(7):427-34. PubMed ID: 16485265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography.
    Koeppe RA; Frey KA; Kume A; Albin R; Kilbourn MR; Kuhl DE
    J Cereb Blood Flow Metab; 1997 Sep; 17(9):919-31. PubMed ID: 9307605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonist binding characteristics of the Ser311-->Cys variant of human dopamine D2 receptor in vivo and in vitro.
    Pohjalainen T; Cravchik A; Gejman PV; Rinne J; Någren K; Syvälahti E; Hietala J
    Biochem Biophys Res Commun; 1997 Mar; 232(1):143-6. PubMed ID: 9125119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Error analysis for quantification of [(11)C]FLB 457 binding to extrastriatal D(2) dopamine receptors in the human brain.
    Ito H; Sudo Y; Suhara T; Okubo Y; Halldin C; Farde L
    Neuroimage; 2001 Mar; 13(3):531-9. PubMed ID: 11170818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.
    Ginovart N; Farde L; Halldin C; Swahn CG
    Synapse; 1997 Apr; 25(4):321-5. PubMed ID: 9097390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains.
    Ekesbo A; Torstenson R; Hartvig P; Carlsson A; Sonesson C; Waters N; Tedroff J; Långström B
    Neuropharmacology; 1999 Mar; 38(3):331-8. PubMed ID: 10219971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of 11C-raclopride binding in the rat brain measured with the microPET R4: effects of scatter correction and tracer specific activity.
    Alexoff DL; Vaska P; Marsteller D; Gerasimov T; Li J; Logan J; Fowler JS; Taintor NB; Thanos PK; Volkow ND
    J Nucl Med; 2003 May; 44(5):815-22. PubMed ID: 12732684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of methods for analysis of clinical [11C]raclopride studies.
    Lammertsma AA; Bench CJ; Hume SP; Osman S; Gunn K; Brooks DJ; Frackowiak RS
    J Cereb Blood Flow Metab; 1996 Jan; 16(1):42-52. PubMed ID: 8530554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.